Este vídeo sobre inovação explica, de uma forma rápida e fácil, como são feitos medicamentos inovadores e como impactam a vida dos pacientes e também quais são os principais desafios pela frente. Ficou curioso? Assista ao vídeo e comente! (Vídeo com legenda adaptada e produzido pela IFPMA – The International Federation of Pharmaceutical Manufacturers &...
Read moreWorld Population Day, on the 11th July, was established by the Governing Council of the United Nations Development Program in 1989. Its aim is to raise awareness of global population problems, with this year’s focus on vulnerable populations in emergencies. This theme is timely—the past 12 months have seen natural disasters strike the populations of...
Read moreThe 2015 Lancet Commission on Health and Climate Change report entitled Health and Climate Change: policy responses to protect public health is a timely and compelling reminder that climate change is exacerbating health issues and will present challenges to efforts by the global community to tackle health concerns and inequalities across the world. Climate change...
Read moreThe 4th African Regulatory Conference generated unprecedented consensus on a shared vision to bring about genuine regulatory harmonization in Africa. Discussions built on the strong foundations laid by African Medicines Regulatory Harmonization (AMRH) that will ultimately shape a new regulatory landscape for Africa. This is a giant leap from when the first African Regulatory Conference...
Read moreItem 11.2 Framework of engagement with non-State actors Delivered by Mario Ottiglio, Director, Public Affairs, Communications and Global Health Policy, IFPMA Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the world. IFPMA welcomes continued efforts to...
Read moreItem 15.1 Antimicrobial resistance Delivered by Nina Grundmann, Policy Analyst, Global Health Policy, IFPMA Thank you for the opportunity to contribute to this important discussion. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the world. IFPMA commends WHO for its efforts to generate a Global Action Plan to...
Read moreItem 17.3 Substandard/spurious/falsely-labelled/falsified/counterfeit medical products Delivered by Cyntia Genolet, Policy Analyst, Regulatory & Health Policy Thank you on behalf of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the...
Read moreIFPMA and its members express our deepest sympathy to people affected by the devastating earthquake that struck Nepal on 25 April 2015. The global research-based pharmaceutical industry represented by the IFPMA is providing significant funds to relief organisations following the major earthquake. The total cash value of the first emergency responses provided so far by...
Read more